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Successful retrograde endovascular reconstruction  
of chronic total occlusion of subclavian vein  
in a haemodialysis-dependent patient — a case report
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Abstract
Unilateral arm swelling without thrombosis is rare. We report a case of significant right arm swelling due to chronic total 
occlusion of the right subclavian vein in a 62 year-old haemodialysis-dependent female patient. Endovascular recon-
struction of the subclavian vein with a 16 × 80 mm Epic balloon-expanding stent (Boston Scientific, USA) was performed 
through the retrograde route for chronic total occlusion, in which a guidewire was passed from the right superior vena 
cava. On the following day, left arm swelling had improved. Nine months following the stent placement, the right arm 
swelling had not recurred.
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Introduction
Central venous stenosis and obstruction is a major con-
cern in patients undergoing prolonged haemodialysis for 
end-stage renal disease. Central venous disease (CVD) 
has been defined as ≥ 50% stenosis involving the internal 
jugular, subclavian, or axillary veins [1]. The incidence of 
central venous stenosis is 25–40% [2]. The main causes 
of central venous stenosis in haemodialysis patients are 
prolonged central venous catheterisation and high-flow 
status in the arteriovenous fistula (AVF) or graft, causing 
intimal trauma or propagation of infection along the veno-
us wall due to secondary infection subsequently leading 
to venous intimal hyperplasia and stenosis [2]. Clinically, 
central venous stenosis manifests as ipsilateral arm or neck 
swelling, elevated venous pressure during haemodialysis, 
and failure of haemodialysis access. This initial phase is 
usually prolonged and asymptomatic, due to the simul-
taneous expansion of dense collateral veins around the 
obstruction that facilitate drainage of the upper extremity. 
Thrombotic occlusion eventually occurs due to stagnant 
and turbulent blood flow in the narrowed segment of the 
subclavian vein. At times, propagation and downstream 
extension of this thrombus into the axillary vein can then 
result in further obstruction of critical collateral veins, 
resulting in an acute clinical presentation. The aim of the 
treatment is to provide symptomatic relief to patients while 
preserving the function of the arterio-venous fistula.
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B). Conquest wire along with finecross microcatheter was 
exchanged with a 0.035-inch extra stiff Terumo guidewire 
(Terumo, Japan) and the lesion was traversed (Figure 5A). 
Lesion was predilated with a 6 × 40 mm and an 8 × 40 
mm Mustang semi-compliant balloon (Boston Scientific, 
USA) at 10 atm pressure for 1 minute (Figure 5B). Lesion 
was stented with a 16 × 80 mm balloon-expandable stent 
and both ends were flared using a high pressure non-
-compliant balloon (Figure 6). During deployment of the 
stent, slight traction was maintained in order to avoid any 
distal migration of the stent. A substantial improvement 
in her swelling was noted the following day and she was 
discharged with aspirin and clopidogrel, 75 mg each, along 
with atorvastatin 20 mg (Figure 1B). Nine months after the 
stent placement, the right arm swelling had not recurred 
with further improvement and with the fistula working quite 
well (Figure 1C).
Discussion
In recent years, as the number of surviving patients with 
end-stage renal disease has increased, so have the com-
plications related to dialysis access. The development of 
central venous disease leads to an increase in arteriove-
nous pressure at the dialysis access site. The resultant 
Case report
A 65 year-old woman, on haemodialysis (HD) for the past 
nine months due to end-stage renal disease, presented with 
gradual onset swelling of her right upper extremity (Figu-
re 1A) which had been noted six months after the creation 
of a native brachial arteriovenous (AV) fistula for HD. Her 
symptoms gradually worsened with inefficient dialysis. Due 
to profound oedema, the veins could be accessed. Right 
femoral vein was accessed and 3,000 U (50 U/kg) of in-
travenous heparin was administered before the procedure. 
Venogram showed total occlusion of right subclavian vein 
(Figure 2C, D). Right superior vena cava was hooked by 6F 
Judkins right guiding catheter (Medtronic, USA). Proximal 
fibrous cap was penetrated with the help of a 0.014-inch 
Conquest Pro 12 guidewire (Asahi, Japan) over Finecross 
microcatheter support (Asahi, Japan) (Figure 3A, B). It was 
dilated with a 1 × 5 mm sapphire balloon (OrbusNeich, 
China). Further advancement of the wire was impossible. 
Therefore, we planned to go with an ipsilateral arterial inje-
ction to delineate the venous course. Right femoral artery 
was accessed and Judkins right diagnostic catheter was 
parked in the right brachial artery. On contrast injection, 
subclavian vein was profiled in delayed levophase showing 
near total narrowing of ostia of subclavian vein (Figure 4A, 
Figure 1. Swelling of right forearm: A. On presentation; B. Next day after stenting, C. At 9-months follow-up
A B C
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used are balloon angioplasty, stenting, and, more recen-
tly, cutting balloon angioplasty, but the optimal manage-
ment strategy is still not clear. Primary stenting has been 
advocated by some for the treatment of CVD [4, 5], while 
others have advocated balloon angioplasty as the prima-
ry treatment, reserving stenting for treatment failure or 
restenosis [6–9]. The most commonly used stents for 
central venous stenosis or occlusion are self-expandable 
stents. On the other hand, balloon-expandable stents are 
venous hypertension causes significant local morbidity 
by causing extremity, neck, and chest swelling. The initial 
management strategies were either surgical ligation of 
the fistula followed by abandonment of the dialysis access 
site, or open surgical repair of the central veins, which is 
associated with high morbidity [3].
The endovascular approach, which started in the 
1980s, for treating central venous stenosis, is now the 
treatment of choice. The various endovascular methods 
Figure 2. Venogram showing total occlusion of right subclavian vein (C, D); Hemiazygous vein (A); Left brachiocephalic vein (B)
A B
C D
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Figure 3A, B. Proximal fibrous cap was penetrated with help of Conquest Pro 12 guidewire over Finecross microcatheter support (red arrow 
— tip of microcatheter)
A B
Figure 4A, B. On contrast injection, subclavian vein was profiled in delayed levophase showing near total narrowing of ostia of subclavian 
vein (red arrow)
A B
used only when the stenosis is short and the diameter is 
large [10]. Although there has been the disadvantage that 
a balloon-expandable stent may have developed compres-
sion or deformation after deployment [10], we decided to 
use a balloon-expandable stent because the subclavian 
vein was larger than the self-expandable stent available 
in India, with commercial sizes up to 12 mm.
The National Kidney Foundation Disease Outcomes 
Quality Initiative guidelines (NKDOQI) have recommended 
angioplasty as the preferred treatment for CVD, with or 
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without stent placement [11]. The diameter of the stent 
should be the same as the adjacent normal vein. Like 
coronary stenting, an appropriate geographical match may 
sometimes not be achieved, and should be better left as 
such because they remodel themselves with time.
More recently, covered stents have also been utilised for 
the treatment of central venous stenosis. A high technical 
success rate with favourable outcomes have been reported 
in the limited literature available on the efficacy of covered 
stents [12]. Thus, covered stents appear to be an effective 
endovascular treatment option. However, their cost remains 
the limiting factor and a cost/benefit analysis should be 
taken into consideration as well. With a bare metal stent, 
primary patency rates at 3, 6 and 12 months are 63–100%, 
42–89%, and 14–73% respectively, as reported in the lite-
rature. Cumulative patency rates are 72–100%, 55–100%, 
and 31–97% at 3, 6, and 12 months respectively [13].
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Figure 6. Well deployed balloon-expandable stent after flaring with 
post deployment high pressure dilation by non-compliant balloon
Figure 5. Lesion crossed with Terumo wire (A); Lesion being predilated with Mustang semicompliant balloon (B)
A B
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Streszczenie
Rzadko obserwuje się jednostronny obrzęk kończyny górnej niespowodowany zakrzepicą. Autorzy opisują przypadek 
znacznego obrzęku prawej ręki z powodu przewlekłej całkowitej niedrożności prawej żyły podobojczykowej u 62-letniej 
hemodializowanej chorej. U pacjentki wykonano zabieg wewnątrznaczyniowej rekonstrukcji żyły podobojczykowej za po-
mocą stentu rozprężanego na balonie Epic 16 × 80 mm (Boston Scientific, Stany Zjednoczone), w którym wprowadzono 
prowadnik do miejsca zwężenia przez prawą żyłę główną górną, wsuwając go w kierunku przeciwnym do przepływu krwi. 
Następnego dnia po zabiegu stwierdzono zmniejszenie obrzęku kończyny. W ciągu 9 miesięcy po wszczepieniu stentu 
nie obserwowano ponownego obrzęku prawej kończyny górnej.
Słowa kluczowe: przewlekła całkowita niedrożność, rekonstrukcja wewnątrznaczyniowa, rekanalizacja wsteczna,  
żyła podobojczykowa, jednostronny obrzęk kończyny górnej
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